Today: 10 November 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Stock Hits a 52-Week Low on Legal Woes Kenvue’s shares collapsed to an all-time low since their mid-2023 IPO, closing around $14 after Thursday’s 13.2% plunge stocktwits.com. The one-day drop – Kenvue’s worst on record – was triggered by headline risks that blindsided investors. By early Friday, October 17, the stock stabilized slightly (up about 0.6% in pre-market trading) after the rout stocktwits.com. Still, at roughly 40% below its IPO price, the Johnson & Johnson spinoff has seen its market capitalization shrink to about $30–31 billion reuters.com. This dramatic sell-off came despite broader markets being relatively calm – the S&P
17 October 2025
 ·  ·  ·  ·  · 
Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Stock Price & Recent Performance Akanda’s stock has been on a rollercoaster. After languishing through 2024 “flying under the radar” stocktitan.net, AKAN came alive this October. The share price erupted over 100% intraday on Oct. 1 amid a burst of interest in the company’s new direction stocktitan.net. Traders cite the ultra-low float – under 0.73 million shares – as a catalyst for these outsized swings. When positive news hits a micro-cap with so few shares available, “even modest buying pressure can create explosive moves” stocktitan.net. Conversely, any wave of selling can also trigger sharp pullbacks, making AKAN a volatile ride.
17 October 2025
 ·  ·  ·  · 
Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Stock Hits Multi-Month Low Amid Legal Fallout Jefferies shares have been on a wild ride in recent weeks, culminating in a steep plunge on October 16. The stock sank intraday to about $50 – territory not seen in over four months – before closing at $48.80, down over 10% for the day stockinvest.us. The selloff erased roughly one-quarter of Jefferies’ market value in just two weeks, capping a slide from the mid-$60s in late September ts2.tech. The immediate trigger for the latest drop was mounting scrutiny over Jefferies’ exposure to a client’s bankruptcy and the wave of shareholder lawsuits that
17 October 2025
 ·  ·  ·  ·  · 
Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Nasdaq Compliance Triggers Relief Rally Safe & Green Holdings Corp. regained compliance with Nasdaq’s listing rules in early October 2025, temporarily boosting its microcap stock price. A week ago, Safe & Green Holdings Corp. (NASDAQ: SGBX) was on the brink of losing its Nasdaq listing – today it’s back in the game, though not without turbulence. The Miami-based modular building and green construction company secured a lifeline on Oct. 9 by regaining compliance with Nasdaq’s $1 minimum bid price requirement, after drastic capital moves to bolster its share price ts2.tech. Nasdaq confirmed the company met listing rules as of Oct.
17 October 2025
 ·  ·  ·  ·  · 
Mortgage Rates Hit 2025 Low at 6.27% – Will They Finally Dip Below 6%?

Mortgage Rates Hit 2025 Low at 6.27% – Will They Finally Dip Below 6%?

Mortgage Rates Near One-Year Low After Fed’s First Cut Mortgage rates have dipped to their lowest levels in about a year, offering American homebuyers a measure of relief after the steep run-up of the past two years. Freddie Mac’s latest survey shows the average 30-year fixed rate at 6.27%, down from 6.3% last week foxbusiness.com. This is just above the year’s low (around 6.26%) reached a month ago and the lowest since early October 2024 apnews.com. By comparison, rates were roughly 6.44% a year ago and had peaked just above 7% in January apnews.com, so borrowing costs are off their
17 October 2025
 ·  ·  ·  · 
Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Nasdaq Compliance Deadlines Loom Carbon Revolution is under intense pressure to shore up its Nasdaq listing status. On July 16, the Australia-based company disclosed it had received a non-compliance notice for falling short of Nasdaq’s minimum shareholder equity requirement of $10 million stocktitan.net. The deficiency was evident in its FY2024 financials, and Nasdaq gave Carbon Revolution 45 days to submit a plan to regain compliance stocktitan.net. If that plan is accepted, the company could get up to 180 days (until ~Nov. 26, 2025) to rebuild its equity base or otherwise meet listing standards stocktitan.net. Failure to do so would put
17 October 2025
 ·  ·  ·  ·  · 
Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Market Selloff Fueled by Loan Fraud Fears Wall Street skidded into the red late this week as fear of hidden loan losses gripped the market. On Thursday (Oct. 16), the Dow, S&P 500, and Nasdaq all closed sharply lower – around 0.5%–1% down each for the day reuters.com – after early gains evaporated. The Dow Jones index gave up roughly 300–400 points, about 0.65%, by the closing bell reuters.com. The reversal came suddenly after midday news of loan problems at two regional banks hit traders’ screens. “Signs of weakness in regional banks spooked investors already on edge,” Reuters noted, especially
17 October 2025
 ·  ·  ·  · 
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

In summary, Artiva Biotherapeutics stock has erupted in October 2025 on the back of a major FDA Fast Track win and renewed optimism around its NK-cell therapy for RA. The latest developments – from surging share price and volume to analyst projections of multi-fold upside – underscore the high stakes and high hopes riding on AlloNK’s success. For biotech investors and observers, ARTV will be a stock to watch closely in the coming months, as upcoming trial data and FDA feedback chart the next chapter for this promising yet still speculative biotech play. Latest Stock Price and Trend Analysis 247marketnews.com
17 October 2025
 ·  ·  ·  ·  · 
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Earnings Beat Sparks Relief Rally Truist’s third-quarter results breezed past expectations, providing a jolt of good news for the regional banking sector. Net income available to common shareholders came in at $1.35 billion (EPS $1.04), exceeding analysts’ $0.99 forecast investing.com and slightly above $0.99 in the prior-year quarter. Revenue of $5.24 billion (taxable-equivalent) was roughly in line with estimates investing.com, as strong fee-based income made up for softer interest income. “Truist delivered strong third-quarter results, underscored by robust fee income growth in investment banking and trading and wealth, healthy loan expansion, and continued expense and credit discipline,” said CEO Bill Rogers in
17 October 2025
 ·  ·  ·  ·  · 
Regional Bank Fraud Scare Sparks Panic – Is a Fed Rate Cut on the Horizon?

Regional Bank Fraud Scare Sparks Panic – Is a Fed Rate Cut on the Horizon?

Surprise Loan Frauds at Regional Banks Shake Confidence Mid-sized banks shocked Wall Street this week with alarming disclosures of bad loans. Zions Bancorporation – a Utah-based regional lender – stunned investors by announcing a $50 million charge-off tied to two commercial loans that it says were compromised by fraud theguardian.com. In an SEC filing, Zions reported “misrepresentations and contractual defaults” by the borrowers and moved to accelerate the loans to default and sue the guarantors ts2.tech ts2.tech. Western Alliance, a Phoenix-based peer, also revealed it is dealing with a fraudulent borrower, having filed a lawsuit back in August after the client
17 October 2025
 ·  ·  ·  · 
Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Rally Stalls at “Uptober” Highs, Then a Healthy Reset October started with a bang for Solana – the coin surged roughly 25% in early “Uptober,” briefly spiking above $250 around Oct. 6 ts2.tech. That marked Solana’s strongest price since January and capped a massive run-up from its 2024 lows. The rally was fueled by broad crypto momentum and anticipation of Solana ETF approvals, along with big institutional buys. By mid-month, however, SOL lost steam. After peaking near $240–$250, it reversed sharply, slipping below $220 and even $200 as traders took profits ts2.tech ts2.tech. As of Oct. 17, Solana hovers in
17 October 2025
 ·  ·  ·  ·  · 
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SOFI Stock Price: 2025 Surge and Recent Volatility After a spectacular rally through 2025, SoFi’s share price has been on a roller coaster in recent weeks. The stock more than tripled in the past year, climbing from the single digits to a high of about $30.30 by late September ts2.tech. That ~230% year-over-year gain far outpaced most fintech and bank stocks. However, the euphoria has cooled slightly in October: SoFi pulled back roughly 10% from its peak, trading in the mid-$20s as some investors took profits ts2.tech. The past week highlighted SoFi’s high volatility. Shares briefly rebounded above $28 mid-week,
17 October 2025
 ·  ·  ·  ·  · 
1 … 63 64 65 66 67 … 171
Go toTop